Financials
- Market Capitalization 413.44 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.14
Fiyat/satışlar oranı
26.03
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3054 | ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 14.65 USD | -9.40% | +10.40% | +154.78% | -13.98% | 416.40 M USD | ||
| 3056 | GALT Galectin Therapeutics Inc. - Common Stock | 4.05 USD | -2.17% | +8.29% | +18.08% | -3.57% | 408.44 M USD | ||
| 3063 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 11.77 USD | -3.29% | +2.97% | +17.00% | +31.36% | 412.74 M USD | ||
| 3071 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.78 USD | -4.21% | -5.53% | +8.88% | -0.62% | 392.18 M USD |